跳至主要内容
临床试验/NCT06021275
NCT06021275招募中不适用

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars

Alexandria University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Change in Scar

研究概览

简要总结

Recently, few studies have attempted to test the regenerative effects of human insulin application by microneedling on atrophic scars versus other topical preparations. However, the scars were limited etiologically to acne scars. In addition, a lack of inclusion of a control group instead of comparing topical preparations with insulin was also a limitation to these studies. A control group consisting of microneedling alone would have served as a better comparison in order to determine whether the effects of microneedling are augmented by topical protein-rich preparations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
12 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 12 to 60 years
  • Atrophic scars (traumatic or surgical)
  • Completely healed scars

排除标准

  • Patients with a tendency or history of hypertrophic or keloidal scars
  • Patients who received treatment for their scar in the past 3 months
  • Diabetic patients or those with a history of Dysglycemia
  • Pregnant, or lactating females
  • Patients with active infection at the site of scar
  • Patients currently receiving isotretinoin treatment or in the past month

结局指标

主要结局

Change in Scar

时间窗: 4 months

According the different scar assessment scores (e.g.POSAS score - The Patient and Observer Scar Assessment Scale score, range from 6 to 60, the higher the score the worse the scar, lowering in the score denotes improvement )

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dalia Ibrahim Halwag

Lecturer and Consultant of Dermatology, Venereology and Andrology, Faculty of Medicine

Alexandria University

研究点 (1)

Loading locations...

相似试验